Differential effects of TGF-β1 on telomerase activity in thyroid carcinoma cell lines

Biochemical and Biophysical Research Communications

Volumn 338, Issue 3, 2005, Pages 1625-1633

  Lindkvist, Anna ^a   Franzén, Åsa ^a   Ren, Zhi Ping ^a   Heldin, Nils Erik ^a   Paulsson Karlsson, Ylva ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaplastic thyroid carcinoma; c Myc; hTERT promoter; p53; Telomerase; TGF 1

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN P53; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THYROID CARCINOMA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TUMOR; DOWN-REGULATION; GENOTYPE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TELOMERASE; THYROID NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 27744546229     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.10.131     Document Type: Article

References (49)

1. N.W. Kim, M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L. Ho, G.M. Coviello, W.E. Wright, S.L. Weinrich, and J.W. Shay Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
2. L. Hayflick, and P.S. Moorhead The serial cultivation of human diploud cell strains Exp. Cell Res. 25 1961 585 621
3. A.G. Bodnar, M. Ouellette, M. Frolkis, S.E. Holt, C.P. Chiu, G.B. Morin, C.B. Harley, J.W. Shay, S. Lichtsteiner, and W.E. Wright Extension of life-span by introduction of telomerase into normal human cells Science 279 1998 349 352
4. C.W. Greider, and E.H. Blackburn The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity Cell 51 1987 887 898
5. J. Feng, W.D. Funk, S.S. Wang, S.L. Weinrich, A.A. Avilion, C.P. Chiu, R.R. Adams, E. Chang, R.C. Allsopp, and J. Yu The RNA component of human telomerase Science 269 1995 1236 1241
6. M. Meyerson, C.M. Counter, E.N. Eaton, L.W. Ellisen, P. Steiner, S.D. Caddle, L. Ziaugra, R.L. Beijersbergen, M.J. Davidoff, Q. Liu, S. Bacchetti, D.A. Haber, and R.A. Weinberg hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization Cell 90 1997 785 795
7. T.M. Nakamura, G.B. Morin, K.B. Chapman, S.L. Weinrich, W.H. Andrews, J. Lingner, C.B. Harley, and T.R. Cech Telomerase catalytic subunit homologs from fission yeast and human Science 277 1997 955 959
8. C.B. Harley, A.B. Futcher, and C.W. Greider Telomeres shorten during ageing of human fibroblasts Nature 345 1990 458 460
9. H. Kim, S. You, J. Farris, B.W. Kong, S.A. Christman, L.K. Foster, and D.N. Foster Expression profiles of p53-, p16(INK4a)-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells Exp. Cell Res. 272 2002 199 208
10. S. Kyo, M. Takakura, T. Taira, T. Kanaya, H. Itoh, M. Yutsudo, H. Ariga, and M. Inoue Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) Nucleic Acids Res. 28 2000 669 677
11. D. Xu, N. Popov, M. Hou, Q. Wang, M. Bjorkholm, A. Gruber, A.R. Menkel, and M. Henriksson Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells Proc. Natl. Acad. Sci. USA 98 2001 3826 3831
12. C. Gunes, S. Lichtsteiner, A.P. Vasserot, and C. Englert Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1 Cancer Res. 60 2000 2116 2121
13. S.S. Kang, T. Kwon, D.Y. Kwon, and S.I. Do Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit J. Biol. Chem. 274 1999 13085 13090
14. G.A. Ulaner, J.F. Hu, T.H. Vu, H. Oruganti, L.C. Giudice, and A.R. Hoffman Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium, and myometrium Int. J. Cancer 85 2000 330 335
15. M.P. de Caestecker, E. Piek, and A.B. Roberts Role of transforming growth factor-beta signaling in cancer J. Natl. Cancer Inst. 92 2000 1388 1402
16. C.H. Heldin, K. Miyazono, and P. ten Dijke TGF-beta signalling from cell membrane to nucleus through SMAD proteins Nature 390 1997 465 471
17. M.T. Hartsough, and K.M. Mulder Transforming growth factor-beta signaling in epithelial cells Pharmacol. Ther. 75 1997 21 41
18. G. Lagna, A. Hata, A. Hemmati-Brivanlou, and J. Massague Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways Nature 383 1996 832 836
19. J.A. Pietenpol, J.T. Holt, R.W. Stein, and H.L. Moses Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation Proc. Natl. Acad. Sci. USA 87 1990 3758 3762
20. Y. Katakura, E. Nakata, T. Miura, and S. Shirahata Transforming growth factor beta triggers two independent-senescence programs in cancer cells Biochem. Biophys. Res. Commun. 255 1999 110 115
21. H. Yang, S. Kyo, M. Takatura, and L. Sun Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells Cell Growth Differ. 12 2001 119 127
22. A. Cerezo, H. Kalthoff, M. Schuermann, B. Schafer, and P. Boukamp Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT J. Cell Sci. 115 2002 1305 1312
23. S. Rama, Y. Suresh, and A.J. Rao Regulation of telomerase during human placental differentiation: a role for TGFbeta1 Mol. Cell. Endocrinol. 182 2001 233 248
24. K.B. Ain Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches Thyroid 8 1998 715 726
25. N.E. Heldin, D. Cvejic, S. Smeds, and B. Westermark Coexpression of functionally active receptors for thyrotropin and platelet-derived growth factor in human thyroid carcinoma cells Endocrinology 129 1991 2187 2193
26. J. Carlsson, K. Nilsson, B. Westermark, J. Ponten, C. Sundstrom, E. Larsson, J. Bergh, S. Pahlman, C. Busch, and V.P. Collins Formation and growth of multicellular spheroids of human origin Int. J. Cancer 31 1983 523 533
27. J. Mark, C. Ekedahl, R. Dahlenfors, and B. Westermark Cytogenetical observations in five human anaplastic thyroid carcinomas Hereditas 107 1987 163 174
28. K.B. Ain, and K.D. Taylor Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro J. Clin. Endocrinol. Metab. 78 1994 1097 1102
29. J. Kurebayashi, K. Tanaka, T. Otsuki, T. Moriya, H. Kunisue, M. Uno, and H. Sonoo All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1 J. Clin. Endocrinol. Metab. 85 2000 2889 2896
30. G.A. Ulaner, J.F. Hu, T.H. Vu, L.C. Giudice, and A.R. Hoffman Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts Cancer Res. 58 1998 4168 4172
31. H. Axelson, M. Henriksson, Y. Wang, K.P. Magnusson, and G. Klein The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas Eur. J. Cancer 31A 1995 2099 2104
32. A. Roivainen, L. Pirila, T. Yli-Jama, H. Laaksonen, and P. Toivanen Expression of the myc-family proto-oncogenes and related genes max and mad in synovial tissue Scand. J. Rheumatol. 28 1999 314 318
33. A. Kilian, D.D. Bowtell, H.E. Abud, G.R. Hime, D.J. Venter, P.K. Keese, E.L. Duncan, R.R. Reddel, and R.A. Jefferson Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types Hum. Mol. Genet. 6 1997 2011 2019
34. Y.S. Cong, J. Wen, and S. Bacchetti The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter Hum. Mol. Genet. 8 1999 137 142
35. G. Brenning The in vitro effect of leucocyte alpha-interferon on human myeloma cells in a semisolid agar culture system Scand. J. Haematol. 35 1985 178 185
36. T. Leitner, E. Halapi, G. Scarlatti, P. Rossi, J. Albert, E.M. Fenyo, and M. Uhlen Analysis of heterogeneous viral populations by direct DNA sequencing Biotechniques 15 1993 120 127
37. N.E. Heldin, D. Bergstrom, A. Hermansson, A. Bergenstrahle, A. Nakao, B. Westermark, and P. ten Dijke Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells Mol. Cell. Endocrinol. 153 1999 79 90
38. D. Xu, Q. Wang, A. Gruber, M. Bjorkholm, Z. Chen, A. Zaid, G. Selivanova, C. Peterson, K.G. Wiman, and P. Pisa Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells Oncogene 19 2000 5123 5133
39. M.R. Stampfer, J. Garbe, T. Nijjar, D. Wigington, K. Swisshelm, and P. Yaswen Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines Oncogene 22 2003 5238 5251
40. R. Rahman, L. Latonen, and K.G. Wiman hTERT antagonizes p53-induced apoptosis independently of telomerase activity Oncogene 24 2005 1320 1337
41. L. Boldrini, P. Faviana, S. Gisfredi, V. Donati, Y. Zucconi, S. Ursino, P. Simi, F. Baldinotti, P. Berti, D. Galleri, G. Materazzi, F. Basolo, P. Miccoli, R. Pingitore, and G. Fontanini Regulation of telomerase and its hTERT messenger in colorectal cancer Oncol. Rep. 11 2004 395 400
42. S.Y. Lin, and S.J. Elledge Multiple tumor suppressor pathways negatively regulate telomerase Cell 113 2003 881 889
43. J.C. Poole, L.G. Andrews, and T.O. Tollefsbol Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT) Gene 269 2001 1 12
44. S. Rama, Y. Suresh, and A.J. Rao TGF beta1 induces multiple independent signals to regulate human trophoblastic differentiation: mechanistic insights Mol. Cell. Endocrinol. 206 2003 123 136
45. T.F. Franke, D.R. Kaplan, and L.C. Cantley PI3K: downstream AKTion blocks apoptosis Cell 88 1997 435 437
46. H. Seimiya, M. Tanji, T. Oh-hara, A. Tomida, I. Naasani, and T. Tsuruo Hypoxia up-regulates telomerase activity via mitogen-activated protein kinase signaling in human solid tumor cells Biochem. Biophys. Res. Commun. 260 1999 365 370
47. F. Frasca, V. Vella, A. Aloisi, A. Mandarino, E. Mazzon, R. Vigneri, and P. Vigneri p73 tumor-suppressor activity is impaired in human thyroid cancer Cancer Res. 63 2003 5829 5837
48. M. Kusumoto, T. Ogawa, K. Mizumoto, H. Ueno, H. Niiyama, N. Sato, M. Nakamura, and M. Tanaka Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells Clin. Cancer Res. 5 1999 2140 2147
49. T. Kanaya, S. Kyo, K. Hamada, M. Takakura, Y. Kitagawa, H. Harada, and M. Inoue Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription Clin. Cancer Res. 6 2000 1239 1247